{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:08:05Z","timestamp":1784758085792,"version":"3.55.0"},"reference-count":28,"publisher":"Society of Nuclear Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.2967\/jnumed.122.263962","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T20:20:21Z","timestamp":1660854021000},"page":"109-116","source":"Crossref","is-referenced-by-count":13,"title":["Cure of Micrometastatic B-Cell Lymphoma in a SCID Mouse Model Using<sup>213<\/sup>Bi-Anti-CD20 Monoclonal Antibody"],"prefix":"10.2967","volume":"64","author":[{"given":"Gregory T.","family":"Havlena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav S.","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Engles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Brechbiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Sgouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Wahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,8,18]]},"reference":[{"key":"2023031310502072000_64.1.109.1","first-page":"693","article-title":"Targeted therapy of cancer with radiolabeled antibodies","volume":"43","author":"Goldenberg","year":"2002","journal-title":"J Nucl Med"},{"key":"2023031310502072000_64.1.109.2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40658-017-0193-4","article-title":"Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey","volume":"4","author":"Sj\u00f6green Gleisner","year":"2017","journal-title":"EJNMMI Phys"},{"key":"2023031310502072000_64.1.109.3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0756"},{"key":"2023031310502072000_64.1.109.4","first-page":"457","article-title":"Y-90 labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma","volume":"2","author":"Knox","year":"1996","journal-title":"Clin Cancer Res"},{"key":"2023031310502072000_64.1.109.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-005-6195-z"},{"key":"2023031310502072000_64.1.109.6","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0360-3016(96)00616-5","article-title":"Magnetically-enhanced radionuclide therapy (MERiT): in\u00a0vitro evaluation","volume":"37","author":"Raylman","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2023031310502072000_64.1.109.7","doi-asserted-by":"publisher","DOI":"10.1667\/RR0668.1"},{"key":"2023031310502072000_64.1.109.8","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3569"},{"key":"2023031310502072000_64.1.109.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1213755"},{"key":"2023031310502072000_64.1.109.10","doi-asserted-by":"publisher","DOI":"10.2144\/000112515"},{"key":"2023031310502072000_64.1.109.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8051(03)00082-9"},{"key":"2023031310502072000_64.1.109.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-282327"},{"key":"2023031310502072000_64.1.109.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1228-8"},{"key":"2023031310502072000_64.1.109.14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2310\/7290.2007.00031","article-title":"How reproducible is bioluminescent imaging of tumor cell growth? single time point v.s. dynamic measurement approach","volume":"6","author":"Baba","year":"2007","journal-title":"Mol Imaging"},{"key":"2023031310502072000_64.1.109.15","first-page":"166","article-title":"Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry","volume":"40","author":"Nikula","year":"1999","journal-title":"J Nucl Med"},{"key":"2023031310502072000_64.1.109.16","doi-asserted-by":"crossref","unstructured":"Brechbiel MW Gansow OA . Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labelling of monoclonal antibodies with the bismuth-212 \u03b1-particle emitter. J Chem Soc, Perkin Trans 1. 1992;(9):1173\u20131178.","DOI":"10.1039\/P19920001173"},{"key":"2023031310502072000_64.1.109.17","doi-asserted-by":"publisher","DOI":"10.1021\/bc00016a014"},{"key":"2023031310502072000_64.1.109.18","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(84)90435-6"},{"key":"2023031310502072000_64.1.109.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-8043(98)00151-1"},{"key":"2023031310502072000_64.1.109.20","first-page":"450","article-title":"Accurate dose calibrator activity measurement of 90Y-ibritumomab tiuxetan","volume":"45","author":"Siegel","year":"2004","journal-title":"J Nucl Med"},{"key":"2023031310502072000_64.1.109.21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.18632\/oncotarget.817","article-title":"Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells","volume":"4","author":"Roscher","year":"2013","journal-title":"Oncotarget"},{"key":"2023031310502072000_64.1.109.22","unstructured":"Schmidt D Neumann F Antke C . Phase 1 clinical study on alpha-therapy for non-Hodgkin lymphoma. In: Proceedings of the 4th Alpha-Immunotherapy Symposium. ITU: Dusseldorf, Germany; 2004:12."},{"key":"2023031310502072000_64.1.109.23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-11-612770"},{"key":"2023031310502072000_64.1.109.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-175125"},{"key":"2023031310502072000_64.1.109.25","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/s41416-021-01585-6","article-title":"Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma","volume":"125","author":"Durand-Panteix","year":"2021","journal-title":"Br J Cancer"},{"key":"2023031310502072000_64.1.109.26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-01-066803"},{"key":"2023031310502072000_64.1.109.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.04.062"},{"key":"2023031310502072000_64.1.109.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041511"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.122.263962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T17:53:27Z","timestamp":1678730007000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.122.263962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,4]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.2967\/jnumed.122.263962"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.122.263962","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]}}}